EATRIS-Inside was successfully piloted with the 2014 ZonMw 2TREAT call ... read more.
Translational medicine is the transformation of laboratory research outcomes into new ways to diagnose and treat patients to improve the health of millions of people worldwide. It takes promising biomedical innovations 'from bench to bedside' and bridges clinical needs from bedside to bench.
EATRIS provides a new development pathway, open to researchers and companies in need of support for advancing biomedical innovations. EATRIS comprises over 70 leading academic institutions across Europe, each renowned for its individual and high-end research facilities.
This infrastructure provides the following advantages:
- Single point of access to the right expertise and facilities
- Expedites the development process
- Access to large and diverse clinical patient cohorts
Translational Science on the Global Stage ... read more.
EATRIS participation as interested party ... read more.
Professor of pathology at VU University Medical Center to serve ... read more.
Frontiers in Regenerative Medicine conference at the Biotechnology Centre in Turin ... read more.
EATRIS Developed Collaboration to Accelerate the Validation of New Thyroid Cancer Diagnostic ... read more.
The European Medicines Agency (EMA) has adopted a landmark policy to take effect on 1 January 2015 ... read more
Building bridges in translational medicine
27th and 28th May 2015, Amsterdam ... read more
Collaboration with EARL to establish a Zirconium PET/CT accreditation programme ... read more
Frontiers in Regenerative Medicine, Molecular Biotechnology Centre, Turin, Italy
Innovation for Health - Shaping the future of healthcare together, the Netherlands.
1st Danish Symposium on Biomarkers and the Implementation of Personalized Medicine to the Clinic, Copenhagen.